Variables |
Total N=3331 |
Death N=508 |
Follow up (person-years) |
Follow up (person-years) |
Mortality(/100 person years) |
Sex |
|
|
|
|
|
Female |
1600 (48%) |
218(42.91%) |
218(42.91%) |
14234 |
1.53 |
Male |
1731 (52%) |
290(57.09%) |
290(57.09%) |
12754 |
2.27 |
Age (year) |
|
|
|
|
|
<40 |
646 (19.4%) |
65 (12.80%) |
65 (12.80%) |
5408 |
1.20 |
40-50 |
1749 (52.5%) |
223 (43.90%) |
223 (43.90%) |
14426 |
1.55 |
50-60 |
936 (28.1%) |
220 (43.31%) |
220 (43.31%) |
7154 |
3.08 |
Marital Status |
|
|
|
|
|
Married |
2461 (73.9%) |
342 (67.32%) |
342 (67.32%) |
20095 |
1.70 |
Sig/window |
870 (26.1%) |
166 (32.68%) |
166 (32.68%) |
6893 |
2.41 |
Educational Status |
|
|
|
|
|
≤6years |
1978 (59.4%) |
324 (63.78%) |
324 (63.78%) |
15746 |
2.06 |
>6years |
1353 (40.6%) |
184 (36.22%) |
184 (36.22%) |
11242 |
1.64 |
HIV transmission mode |
|
|
|
|
|
Others |
681 (20.4%) |
93 (18.31%) |
93 (18.31%) |
5597 |
1.66 |
Plasma |
2650 (79.6%) |
415 (81.69%) |
415 (81.69%) |
21391 |
1.94 |
Time on HIV Positive (year) |
Time on HIV Positive (year) |
|
|
|
|
<5 |
529 (8.53%) |
91 (17.91%) |
91 (17.91%) |
4428 |
2.06 |
5-8 |
1800 (54.0%) |
287 (56.50%) |
287 (56.50%) |
15006 |
1.91 |
>8 |
1002 (30.1%) |
130 (25.59%) |
130 (25.59%) |
7554 |
1.72 |
Time on ART before Second-line (year) |
Time on ART before Second-line
(year) |
Time on ART before Second-line (year) |
Time on ART before
Second-line (year) |
|
|
<3 |
817 (24.5%) |
132(25.98%) |
132(25.98%) |
6523 |
2.02 |
3-6 |
1098 (33.0%) |
155 (30.51%) |
155 (30.51%) |
9008 |
1.72 |
>6 |
1416 (42.5%) |
221 (43.50%) |
221 (43.50%) |
11457 |
1.93 |
Chinese Medicine Therapy |
Chinese Medicine Therapy |
|
|
|
|
No |
2684 (80.6%) |
430 (84.65%) |
430 (84.65%) |
21724 |
1.98 |
Yes |
647 (19.4%) |
78 (15.35%) |
78 (15.35%) |
5264 |
1.48 |
CD4+ Cell Count (cells/ μl) |
CD4+ Cell Count (cells/ μl) |
|
|
|
|
<200 |
1005 (30.2%) |
202 (39.76%) |
202 (39.76%) |
7853 |
2.57 |
200-350 |
1013 (30.4%) |
157 (30.91%) |
157 (30.91%) |
8304 |
1.89 |
350-500 |
691 (20.7%) |
79 (15.55%) |
79 (15.55%) |
5711 |
1.38 |
>500 |
622 (18.7%) |
70 (13.78%) |
70 (13.78%) |
5120 |
1.37 |
Anemia |
|
|
|
|
|
Unclear |
1522(45.7%) |
250(49.21%) |
250(49.21%) |
12039 |
2.08 |
No |
1426 (42.8%) |
197 (38.78%) |
197 (38.78%) |
11853 |
1.66 |
Yes |
383 (11.5%) |
61 (12.01%) |
61 (12.01%) |
3096 |
1.97 |
Liver injury |
|
|
|
|
|
Unclear |
1002 (30.1%) |
163 (32.9%) |
163 (32.9%) |
7727 |
2.11 |
No |
2043 (61.3%) |
288 (56.69%) |
288 (56.69%) |
17014 |
1.69 |
Yes |
286 (8.59%) |
57 (11.22%) |
57 (11.22%) |
2247 |
2.54 |
Hyperlipidemia |
|
|
|
|
|
Unclear |
2177 (65.4%) |
341 (67.13%) |
341 (67.13%) |
17567 |
1.94 |
No |
854 (25.6%) |
126 (24.80%) |
126 (24.80%) |
6899 |
1.83 |
Yes |
300 (9.01%) |
41 (8.07%) |
41 (8.07%) |
2522 |
1.63 |